Patents by Inventor Mark Hasleton

Mark Hasleton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF SEROTONIN REUPTAKE INHIBITOR WITHDRAWAL SYNDROME
    Publication number: 20240277654
    Abstract: The present invention relates to a method of treating serotonin reuptake inhibitor withdrawal syndrome comprising the administration of a therapeutically effective amount of escitalopram gentisate.
    Type: Application
    Filed: July 6, 2022
    Publication date: August 22, 2024
    Inventor: Mark HASLETON
  • TREATMENT AND/OR REDUCTION OF OCCURRENCE OF MIGRAINE
    Publication number: 20240139171
    Abstract: There is described a method of treating migraine in certain subjects suffering from migraine, by administration of a gepant to the subject. Also described is a method of reducing the incidence of migraine in certain subjects suffering from migraine, by administration of a gepant to the subject. Also described are methods for identifying the certain subjects. Other embodiments are also disclosed.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 2, 2024
    Inventor: Mark HASLETON
  • PHARMACEUTICAL DOSAGE FORM
    Publication number: 20240100012
    Abstract: There are disclosed are pharmaceutical dosage forms comprising escitalopram base, as well as the use of the dosage forms in the treatment of certain conditions. Other embodiments are also disclosed.
    Type: Application
    Filed: January 17, 2022
    Publication date: March 28, 2024
    Inventor: Mark HASLETON
  • TREATMENT OF MIGRAINE
    Publication number: 20240092880
    Abstract: The present invention relates to methods for the preventive treatment of migraine in a subject comprising administering to said subject that does not exhibit signs of allodynia and/or hyperalgesia at least twenty-four hours into the post-ictal phase, an anti-PACAP agent.
    Type: Application
    Filed: October 4, 2022
    Publication date: March 21, 2024
    Inventor: Mark Hasleton
  • Salt and solid state forms of escatalopram
    Patent number: 11897858
    Abstract: The present disclosure relates to a new salt of escitalopram and its solid state forms, processes for the preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: July 17, 2022
    Date of Patent: February 13, 2024
    Inventor: Mark Hasleton
  • SALT AND SOLID STATE FORMS OF ESCATALOPRAM
    Publication number: 20220363655
    Abstract: The present disclosure relates to a new salt of escitalopram and its solid state forms, processes for the preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: July 17, 2022
    Publication date: November 17, 2022
    Inventor: Mark Hasleton
  • Salt and solid state forms of escitalopram
    Patent number: 11390597
    Abstract: The present disclosure relates to a new salt of escitalopram and its solid state forms, processes for the preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: July 19, 2022
    Inventor: Mark Hasleton